Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen M Mullane

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Expert Review of Anti-Infective Therapy|August 4, 2011
Fidaxomicin: first-in-class macrocyclic antibioticKathleen M Mullane, Sherwood Gorbach
Infection and Drug Resistance|July 12, 2013
Emerging therapies for Clostridium difficile infection - focus on fidaxomicinFredy Chaparro-Rojas, Kathleen M Mullane
Clinical Transplantation|April 20, 2019
Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of PracticeKathleen M Mullane, Erik R Dubberke,
Practical Radiation Oncology|March 14, 2014
Herpes zoster and radiation therapy: what radiation oncologists need to know about diagnosing, preventing, and treating herpes zosterMeghan W Macomber, Kathleen M Mullane, Stanley L Liauw
Antimicrobial Agents and Chemotherapy|February 14, 2013
Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilmR Estes, J Theusch, A Beck, et al.
Surgical Infections|June 3, 2009
Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive diseaseJames J Mezhir, Kathleen M Mullane, Joel Zarling, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trialChristine H Lee, Hernando Patino, Chris Stevens, et al.
Laboratory Medicine|May 23, 2024
Expect the unexpected: endocarditis caused by Legionella feeleiiAngelica Moran, Dennise E Otero Espinal, Megan Parilla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2020
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?Natasha N Pettit, Jennifer Pisano, Cynthia T Nguyen, et al.
Transplantation and Cellular Therapy|February 24, 2022
American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant RecipientsCarolyn D Alonso, Gabriela Maron, Mini Kamboj, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Expert Review of Anti-Infective Therapy|August 4, 2011
Fidaxomicin: first-in-class macrocyclic antibioticKathleen M Mullane, Sherwood Gorbach
Infection and Drug Resistance|July 12, 2013
Emerging therapies for Clostridium difficile infection - focus on fidaxomicinFredy Chaparro-Rojas, Kathleen M Mullane
Clinical Transplantation|April 20, 2019
Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of PracticeKathleen M Mullane, Erik R Dubberke,
Practical Radiation Oncology|March 14, 2014
Herpes zoster and radiation therapy: what radiation oncologists need to know about diagnosing, preventing, and treating herpes zosterMeghan W Macomber, Kathleen M Mullane, Stanley L Liauw
Antimicrobial Agents and Chemotherapy|February 14, 2013
Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilmR Estes, J Theusch, A Beck, et al.
Surgical Infections|June 3, 2009
Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive diseaseJames J Mezhir, Kathleen M Mullane, Joel Zarling, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trialChristine H Lee, Hernando Patino, Chris Stevens, et al.
Laboratory Medicine|May 23, 2024
Expect the unexpected: endocarditis caused by Legionella feeleiiAngelica Moran, Dennise E Otero Espinal, Megan Parilla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2020
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?Natasha N Pettit, Jennifer Pisano, Cynthia T Nguyen, et al.
Transplantation and Cellular Therapy|February 24, 2022
American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant RecipientsCarolyn D Alonso, Gabriela Maron, Mini Kamboj, et al.
Pageof 5